May 7, 2017 / 9:06 PM / 3 months ago

BRIEF-Myovant Sciences announces presentation of positive Phase 2 data for Relugolix

May 7 (Reuters) - Myovant Sciences Ltd:

* Myovant Sciences announces presentation of positive phase 2 data for Relugolix in women with heavy menstrual bleeding and uterine fibroids at the annual meeting of the American Congress of Obstetricians and Gynecologists

* Says study met its primary endpoint Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below